@misc{indiciaeecdb8cbf647d,
  title = {Immunometabolic reprogramming by LRH-1/NR5A2 pharmacological activation resolves inflammation in immune cells of type 1 diabetes mellitus individuals and improves human islet engraftment and function},
  author = {Cobo-vuilleumier, N. and Rodriguez-Fernandez, S. and Lopez-Noriega, L. and Lorenzo, P. I. and Franco, J. M. and Lachaud, c. C. and Martin-Vazquez, E. and Araujo Legido, R. and Dorronsoro, A. and Lopez-Fernandez-Sobrino, R. and Salas-Lloret, D. and van Overbeek, N. and Ramos-Rodriguez, M. and Mateo-Rodriguez, C. and Hidalgo, L. and Nano, R. and Arroba, A. I. and Campos Caro, A. and Vertegaal, A. C. and Martin Montalvo, A. and Martin, F. and Aguilar-Diosdado, M. and Piemonti, L. and Pasquali, L. and Gonzalez Prieto, R. and Garcia Sanchez, M. I. and Martinez-Brocca, M. and Vives-Pi, M. and Gauthier, B. R.},
  year = {2023},
  doi = {10.1101/2023.09.18.558230},
  url = {https://www.biorxiv.org/content/10.1101/2023.09.18.558230v1},
  note = {Source identifier: 10.1101/2023.09.18.558230}
}